/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Tolerance Bio

Tolerance Bio

Philadelphia, Pennsylvania, United States

Tolerance Bio increases health span by preserving, restoring, and modulating the function of the thymus, the master regulator of immune tolerance

Healthcare & Biotech

Tolerance Bio, based in Philadelphia, Pennsylvania, United States, has 2 investors on file, among them BioAdvance and Criteria Bio Ventures. Its latest round on record is Series A, 3 Jun 2026. Its site was last checked 6 Nov 2026: site answers.

tolerancebio.com

Funding

1 round on record
Latest roundSeries A3 Jun 2026
Since that round5 monthsno later round on record
Jun 2026Series AInvestors not named

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

2 investors on file
InvestorEvidenceType
BioAdvancePortfolio pageVenture capital
Criteria Bio VenturesPortfolio pageCorporate VC

More from BioAdvance

6 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

Palvella TherapeuticsPalvella Therapeutics exists to address rare skin diseases with no app…Strados LabsStrados Labs provides respiratory endpoint solutions for clinical tria…Vittoria BiotherapeuticsVittoria Biotherapeutics is a clinical-stage company that develops imm…ImmunoGenesisImmunoGenesis is engineering next-generation immunotherapies designed …Latus BioThe company develops gene therapies designed to target the right cell …

See BioAdvance's full profile · Who invests alongside it

More from Criteria Bio Ventures

14 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (87%), Food & Agriculture (7%), Industrial & Manufacturing (7%).

Adaptam TherapeuticsAdaptam Therapeutics is developing antibody-based therapies directed t…CytospireCytospire Therapeutics develops next generation immune cell engagers, …NRG TherapeuticsNRG Therapeutics is developing innovative oral medicines for amyotroph…SpliceBioSpliceBio is a genetic medicines company that develops gene therapies …Aboleris-PharmaAboleris Pharma is a clinical-stage biopharmaceutical company developi…

See Criteria Bio Ventures' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Tolerance Bio and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when BioAdvance adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/tolerancebio.com/investors

# also
GET /v1/companies/tolerancebio.com
GET /v1/companies/tolerancebio.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing